Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram.
Fernandez Montes A, Vazquez Rivera F, Martinez Lago N, Covela Rúa M, Cousillas Castiñeiras A, Gonzalez Villarroel P, de la Cámara Gómez J, Méndez Méndez JC, Salgado Fernández M, Candamio Folgar S, Reboredo López M, Carmona Campos M, Gallardo Martín E, Jorge Fernández M, Pellón Augusto ML, París Bouzas L, García Gómez J. Fernandez Montes A, et al. Clin Transl Oncol. 2020 Mar;22(3):351-359. doi: 10.1007/s12094-019-02130-x. Epub 2019 May 9. Clin Transl Oncol. 2020. PMID: 31073972
Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study.
Sánchez-Cánovas M, Jimenez-Fonseca P, Fernández Garay D, Cejuela Solís M, Casado Elía D, Coma Salvans E, de la Haba Vacas I, Gómez Sánchez D, Fernández Montés A, Morales Giménez R, Biosca Gómez de Tejada M, Arrazubi Arrula V, Sequero López S, Otero Candelera R, Sánchez Cendra C, Justo de la Peña M, Moreno Muñoz D, Orillo Sarmiento M, Martínez de Castro E, García Escobar I, Bernal Vidal A, Ortega Moran L, Muñoz Martín AJ, Sánchez Bayona R, Martínez Ortiz MJ, Ayala de la Peña F, Vicente V, Carmona-Bayonas A. Sánchez-Cánovas M, et al. Among authors: fernandez garay d, fernandez montes a. PLoS One. 2023 May 9;18(5):e0266305. doi: 10.1371/journal.pone.0266305. eCollection 2023. PLoS One. 2023. PMID: 37159465 Free PMC article.
Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study.
Carmona-Bayonas A, Rodriguez-Gonzalez A, García-García T, Velasco-Durantez V, Hernández-San Gil R, Cruz-Castellanos P, Fernandez-Montes A, Castillo-Trujillo A, Ballester I, Rogado J, Calderon C, Jimenez-Fonseca P. Carmona-Bayonas A, et al. Among authors: fernandez montes a. Oncologist. 2023 Nov 2;28(11):986-995. doi: 10.1093/oncolo/oyad100. Oncologist. 2023. PMID: 37185783 Free PMC article.
Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers.
Fernández Montes A, Martínez Lago N, Covela Rúa M, de la Cámara Gómez J, González Villaroel P, Méndez Méndez JC, Jorge Fernández M, Salgado Fernández M, Reboredo López M, Quintero Aldana G, Luz Pellón Augusto M, Graña Suárez B, García Gómez J. Fernández Montes A, et al. Cancer Med. 2019 Mar;8(3):882-889. doi: 10.1002/cam4.1903. Epub 2019 Jan 28. Cancer Med. 2019. PMID: 30690930 Free PMC article.
Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis.
Fernández Montes A, López López C, Argilés Martínez G, Páez López D, López Muñoz AM, García Paredes B, Gutiérrez Abad D, Castañón López C, Jiménez Fonseca P, Gallego Plazas J, López Doldán MC, Martínez de Castro E, Sánchez Cánovas M, Tobeña Puyal M, Llorente Ayala B, Juez Martel I, López Flores M, Carmona-Bayonas A. Fernández Montes A, et al. Oncologist. 2019 Aug;24(8):e687-e695. doi: 10.1634/theoncologist.2018-0824. Epub 2019 May 30. Oncologist. 2019. PMID: 31147489 Free PMC article.
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial.
Quintero Aldana G, Salgado M, Candamio S, Méndez JC, Jorge M, Reboredo M, Vázquez Tuñas L, Romero C, Covela M, Fernández Montes A, Carmona M, Vidal Insua Y, López R; Galician Oncological Research Group (GGIO). Quintero Aldana G, et al. Among authors: fernandez montes a. Clin Transl Oncol. 2020 Apr;22(4):495-502. doi: 10.1007/s12094-019-02151-6. Epub 2019 Jul 6. Clin Transl Oncol. 2020. PMID: 31280434 Clinical Trial.
First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study.
Méndez Méndez JC, Salgado Fernández M, de la Cámara Gómez J, Pellón Augusto ML, Covela Rua M, Quintero Aldana G, Fernández Montes A, Reboredo López M, Valladares Ayerbes M, Jorge Fernández M, González Villarroel P, Romero Reinoso C, Ramos Vázquez M; Galician Research Group on Digestive Tumours (GITuD). Méndez Méndez JC, et al. Among authors: fernandez montes a. J Geriatr Oncol. 2020 Nov;11(8):1263-1267. doi: 10.1016/j.jgo.2020.06.003. Epub 2020 Jun 21. J Geriatr Oncol. 2020. PMID: 32580916 Clinical Trial.
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
Martínez-Lago N, Fernández-Montes A, Covela M, Brozos EM, De la Cámara J, Méndez Méndez JC, Jorge-Fernández M, Cousillas Castiñeiras A, Reboredo C, Arias Ron D, Pellón Augusto ML, González Villarroel P, Graña B, Salgado Fernández M, Carral Maseda A, Vázquez Rivera F, Candamio Folgar S, Reboredo López M; Galician Research Group on Digestive Tumors (GITuD). Martínez-Lago N, et al. Among authors: fernandez montes a. BMC Cancer. 2021 Jan 14;21(1):64. doi: 10.1186/s12885-020-07758-5. BMC Cancer. 2021. PMID: 33446148 Free PMC article.
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study.
Feliu J, Jorge Fernández M, Macarulla T, Massuti B, Albero A, González González JF, Quintero-Aldana G, Delgado-Mingorance JI, Fernández Montes A, García Piernavieja C, Valladares-Ayerbes M, López Muñoz AM, Mondéjar Solís R, Vicente P, Casado Gonzalez E, González Cebrián I, López-Vivanco G. Feliu J, et al. Among authors: fernandez montes a. Cancer Chemother Pharmacol. 2021 Apr;87(4):543-553. doi: 10.1007/s00280-020-04214-w. Epub 2021 Jan 15. Cancer Chemother Pharmacol. 2021. PMID: 33452559 Clinical Trial.
66 results